Structures by: Bardin J.
Total: 10
Creatine form I
C4H9N3O2
CrystEngComm (2014) 16, 35 8197
a=11.9450(2)Å b=9.5273(1)Å c=5.3438(1)Å
α=90° β=90° γ=90°
Creatine formic acid solvate
C4H9N3O2,CH2O2
CrystEngComm (2014) 16, 35 8197
a=17.4929(14)Å b=4.7791(4)Å c=10.1101(8)Å
α=90.00° β=90.00° γ=90.00°
Creatine form I
C4H9N3O2
CrystEngComm (2014) 16, 35 8197
a=11.9450(2)Å b=9.5273(1)Å c=5.3438(1)Å
α=90° β=90° γ=90°
Creatine form II
C4H9N3O2
CrystEngComm (2014) 16, 35 8197
a=9.8450(3)Å b=5.8373(2)Å c=11.6698(3)Å
α=90° β=105.723(2)° γ=90°
Creatine formic acid solvate
C4H9N3O2,CH2O2
CrystEngComm (2014) 16, 35 8197
a=17.4929(14)Å b=4.7791(4)Å c=10.1101(8)Å
α=90.00° β=90.00° γ=90.00°
Carbamazepine trifluoroacetic acid solvate
C15H12N2O,C2HF3O2
Acta Crystallographica Section E (2007) 63, 11 o4269-o4269
a=15.0142(4)Å b=5.28710(10)Å c=20.2489(6)Å
α=90.00° β=101.735(3)° γ=90.00°
Cytenamide trifluoroacetic acid solvate
C16H13NO,C2HF3O2
Acta Crystallographica Section E (2008) 64, 7 o1215-o1216
a=12.1673(11)Å b=6.3235(6)Å c=21.4525(15)Å
α=90° β=101.932(8)° γ=90°
3-Aminocarbonylpyridinium difluoroacetate
C6H7N2O,C2HF2O2
Acta Crystallographica Section E (2009) 65, 11 o2896-o2897
a=4.9888(2)Å b=25.6147(12)Å c=7.2006(4)Å
α=90° β=105.912(2)° γ=90°
Nicotinamide 2,2,2-trifluoroethanol(2/1)
2(C6H6N2O),C2H3F3O
Acta Crystallographica Section E (2009) 65, 4 o727-o728
a=5.0472(3)Å b=11.2930(7)Å c=15.0877(10)Å
α=107.002(3)° β=96.636(3)° γ=95.753(3)°
Creatine form II
C4H9N3O2
CrystEngComm (2014) 16, 35 8197
a=9.8450(3)Å b=5.8373(2)Å c=11.6698(3)Å
α=90° β=105.723(2)° γ=90°